Literature DB >> 11818380

Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy.

Mohamed F El-Ashry1, Mai M Abd El-Aziz, Simon Wilkins, Michael E Cheetham, Susan E Wilkie, Alison J Hardcastle, Stephanie Halford, Ahmed Y Bayoumi, Linda A Ficker, Stephen Tuft, Shomi S Bhattacharya, Neil D Ebenezer.   

Abstract

PURPOSE: Macular corneal dystrophy (MCD) is a rare corneal dystrophy that is characterized by abnormal deposits in the corneal stroma, keratocytes, Descemet's membrane, and endothelium, accompanied by progressive clouding. It has been classified into three immunophenotypes--MCD types I, IA, and II--according to the serum level of sulfated keratan sulfate (KS) and immunoreactivity of the corneal tissue. Recently, mutations in a new carbohydrate sulfotransferase gene (CHST6) encoding corneal glucosamine N-acetyl-6-sulfotransferase (C-GlcNac-6-ST) have been identified as the cause of MCD. Mutation screening of the CHST6 gene has been undertaken to identify the underlying mutations in five unrelated British families with MCD.
METHODS: DNA was extracted from venous blood obtained from all participants, and the coding region of CHST6 was amplified by polymerase chain reaction (PCR). The PCR products were analyzed by direct sequencing and restriction enzyme digestion. Enzyme-linked immunosorbent assay (ELISA) was performed to assess the presence of KS in serum from the probands of MCD-affected families participating in the study.
RESULTS: Six novel missense mutations--four homozygous and two compound heterozygous--were identified in the CHST6 gene. The ELISA showed that the disease in all patients participating in the study was of MCD type I, including the subtype IA.
CONCLUSIONS: These novel mutations are thought to result in loss of corneal sulfotransferase function, which would account for the MCD phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818380

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  Novel CHST6 gene mutations in 2 unrelated cases of macular corneal dystrophy.

Authors:  Dhara A Patel; George J Harocopos; Shu-Hong Chang; Smita C Vora; Anthony J Lubniewski; Andrew Jw Huang
Journal:  Cornea       Date:  2011-06       Impact factor: 2.651

Review 2.  Keratan sulfate biosynthesis.

Authors:  James L Funderburgh
Journal:  IUBMB Life       Date:  2002-10       Impact factor: 3.885

3.  Macular corneal dystrophy: mutational spectrum in German patients, novel mutations and therapeutic options.

Authors:  Claudia Gruenauer-Kloevekorn; Saskia Braeutigam; Wolfram Heinritz; Ursula G Froster; Gernot I W Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-24       Impact factor: 3.117

Review 4.  Glycosylation diseases: quo vadis?

Authors:  Harry Schachter; Hudson H Freeze
Journal:  Biochim Biophys Acta       Date:  2008-11-13

Review 5.  The IC3D classification of the corneal dystrophies.

Authors:  Jayne S Weiss; H U Møller; Walter Lisch; Shigeru Kinoshita; Anthony J Aldave; Michael W Belin; Tero Kivelä; Massimo Busin; Francis L Munier; Berthold Seitz; John Sutphin; Cecilie Bredrup; Mark J Mannis; Christopher J Rapuano; Gabriel Van Rij; Eung Kweon Kim; Gordon K Klintworth
Journal:  Cornea       Date:  2008-12       Impact factor: 2.651

6.  A case of Korean patient with macular corneal dystrophy associated with novel mutation in the CHST6 gene.

Authors:  You Kyung Lee; Dong-Jin Chang; Sung Kun Chung
Journal:  Korean J Ophthalmol       Date:  2013-11-15

7.  Novel mutation in the CHST6 gene causes macular corneal dystrophy in a black South African family.

Authors:  Nadia Carstens; Susan Williams; Saadiah Goolam; Trevor Carmichael; Ming Sin Cheung; Stine Büchmann-Møller; Marc Sultan; Frank Staedtler; Chao Zou; Peter Swart; Dennis S Rice; Arnaud Lacoste; Kim Paes; Michèle Ramsay
Journal:  BMC Med Genet       Date:  2016-07-20       Impact factor: 2.103

8.  Genetic analysis of CHST6 and TGFBI in Turkish patients with corneal dystrophies: Five novel variations in CHST6.

Authors:  Fulya Yaylacioglu Tuncay; Gülsüm Kayman Kurekci; Sezen Guntekin Ergun; Ozge Tugce Pasaoglu; Rustu Fikret Akata; Pervin Rukiye Dincer
Journal:  Mol Vis       Date:  2016-10-26       Impact factor: 2.367

9.  Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase.

Authors:  Yasutaka Hayashida; Tomoya O Akama; Nicola Beecher; Philip Lewis; Robert D Young; Keith M Meek; Briedgeen Kerr; Clare E Hughes; Bruce Caterson; Akira Tanigami; Jun Nakayama; Michiko N Fukada; Yasuo Tano; Kohji Nishida; Andrew J Quantock
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-25       Impact factor: 11.205

10.  Macular corneal dystrophy in a Chinese family related with novel mutations of CHST6.

Authors:  Xiuhong Dang; Qingguo Zhu; Li Wang; Hong Su; Hui Lin; Nan Zhou; Ting Liang; Zheng Wang; Shangzhi Huang; Qiushi Ren; Yanhua Qi
Journal:  Mol Vis       Date:  2009-04-06       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.